SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000950142-14-000717
Filing Date
2014-03-24
Accepted
2014-03-24 16:52:47
Documents
1
Group Members
AISLING CAPITAL III LPAISLING CAPITAL PARTNERS III LLCAISLING CAPITAL PARTNERS III LPANDREW SCHIFFDENNIS PURCELLSTEVE ELMS

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 eh1400476_13da1-durata.htm SC 13D/A 225724
  Complete submission text file 0000950142-14-000717.txt   227417
Mailing Address 888 Seventh Avenue, 30th Fl New York NY 10106
Business Address 888 Seventh Avenue, 30th Fl New York NY 10106 212-651-6380
AISLING CAPITAL III LP (Filed by) CIK: 0001444717 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13D/A

Mailing Address 200 SOUTH WACKER DRIVE SUITE 2550 CHICAGO IL 60606
Business Address 200 SOUTH WACKER DRIVE SUITE 2550 CHICAGO IL 60606 312-219-7000
Durata Therapeutics, Inc. (Subject) CIK: 0001544116 (see all company filings)

IRS No.: 871247903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-86923 | Film No.: 14713665
SIC: 2834 Pharmaceutical Preparations